PHINEST: Promoting Healing of Injured Nerves With Electrical Stimulation Therapy

Sponsor
Checkpoint Surgical Inc. (Industry)
Overall Status
Not yet recruiting
CT.gov ID
NCT05884125
Collaborator
Congressionally Directed Medical Research Programs (U.S. Fed)
60
2
2
48
30
0.6

Study Details

Study Description

Brief Summary

This study is evaluating a new therapeutic use of electrical stimulation to promote nerve healing and improve functional recovery following surgical intervention for peripheral nerve injury in arm. Participants will be randomized into one of two groups, treatment or control, with all participants receiving standard of care treatment for the nerve injury. The treatment group will also receive a single dose of the therapeutic stimulation during the surgical intervention for their nerve injury.

Condition or Disease Intervention/Treatment Phase
  • Device: Checkpoint BEST System
N/A

Detailed Description

Preliminary research has shown that delivering a brief period of electrical stimulation following nerve repair promotes nerve healing and functional recovery. This pilot study is investigating the use of a single dose of therapeutic electrical stimulation to promote nerve healing. The therapy is delivered as part of the surgical intervention to address peripheral nerve injury in the arm.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
60 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Participant, Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Promoting Healing of Injured Nerves With Electrical Stimulation Therapy
Anticipated Study Start Date :
Jun 1, 2023
Anticipated Primary Completion Date :
Jun 1, 2027
Anticipated Study Completion Date :
Jun 1, 2027

Arms and Interventions

Arm Intervention/Treatment
Experimental: Brief Electrical Stimulation Therapy

Single, 10 minute dose of electrical stimulation delivered to the injured nerve during surgical intervention.

Device: Checkpoint BEST System
Single use medical device, consisting of electric stimulator and intraoperative lead. Therapy consists of single, 10 minute dose delivered proximal to site of decompression/repair
Other Names:
  • Brief Electrical Stimulation (BES) Therapy
  • No Intervention: Standard of Care

    Surgical intervention for repair of peripheral nerve injury.

    Outcome Measures

    Primary Outcome Measures

    1. Change in Motor Recovery assessed using the Medical Research Council (MRC) motor grading [Pre-surgery, 2 months, 4 months, 6 months, 8 months, 10 months, 12 months, 15 months, and 18 months]

      Grading of muscle strength on 0 to 5 scale, with higher score representing greater function.

    Secondary Outcome Measures

    1. Grip Strength [Pre-surgery, 2 months, 4 months, 6 months, 8 months, 10 months, 12 months, 15 months, and 18 months]

      Maximum grip strength.

    2. Lateral Pinch Strength [Pre-surgery, 2 months, 4 months, 6 months, 8 months, 10 months, 12 months, 15 months, and 18 months]

      Maximum lateral pinch.

    3. 2-point discrimination [Pre-surgery, 2 months, 4 months, 6 months, 8 months, 10 months, 12 months, 15 months, and 18 months]

      Evaluation of sensory function, measuring tactile discrimination.

    4. Semmes-Weinstein Monofilament Testing [Pre-surgery, 2 months, 4 months, 6 months, 8 months, 10 months, 12 months, 15 months, and 18 months]

      Evaluation of sensory function, measuring pressure detection threshold.

    5. Patient Reported Outcome Measurement System (PROMIS) Upper Extremity Function [Pre-surgery, 10 days, 2 months, 4 months, 6 months, 8 months, 10 months, 12 months, 15 months, and 18 months]

      Questionnaire providing patient reported estimate of upper extremity function on a 0-100 scale with >50 representing greater normal function.

    6. Patient Reported Outcome Measurement System (PROMIS) Pain Interference [Pre-surgery, 10 days, 2 months, 4 months, 6 months, 8 months, 10 months, 12 months, 15 months, and 18 months]

      Questionnaire providing patient reported estimate of interference of pain on daily activities on a 0-100 scale with >50 representing greater than normal pain interference on daily activities.

    7. quick Disabilities of thee Arm, Shoulder, and Hand (DASH) questionnaire [Pre-surgery, 10 days, 2 months, 4 months, 6 months, 8 months, 10 months, 12 months, 15 months, and 18 months]

      Questionnaire providing patient reported estimate upper extremity function. The score ranges from 0 (no disability) to 100 (most severe disability).

    8. Electromyography (EMG) [4 months, 6 months, and 8 months]

      Measurement of the electrical activity in a muscle.

    9. Motor Unit Number Estimation (MUNE) [4 months, 6 months, and 8 months]

      Estimate of the number of motor units within the muscle based on recorded electrical activity.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 80 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Upper extremity mixed or motor nerve injury from the brachial plexus to the wrist crease.

    • Candidate for surgical intervention.

    • Indicated for surgical repair by nerve transfer, primary repair, or nerve grafting.

    • Are age 18-80 years.

    • Signed and dated informed consent form.

    Exclusion Criteria:
    • Severe comorbid condition, such as arrhythmia or congestive heart failure, preventing surgery.

    • Primary repair requiring graft >6cm.

    • Nerve reconstruction occurring >12 months post injury.

    • Age less than 18 or greater than 80 years.

    • All contraindications to included/required surgical procedure, including but not limited to language barriers, mental status barriers, inability to consent, and pregnancy/lactation.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Northwestern Feinberg School of Medicine - Department of Orthopaedic Surgery Chicago Illinois United States 60611
    2 The Ohio State Univeristy - Department of Plastic and Reconstructive Surgery Columbus Ohio United States 43212

    Sponsors and Collaborators

    • Checkpoint Surgical Inc.
    • Congressionally Directed Medical Research Programs

    Investigators

    • Principal Investigator: Amy M Moore, MD, Ohio State University

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    Checkpoint Surgical Inc.
    ClinicalTrials.gov Identifier:
    NCT05884125
    Other Study ID Numbers:
    • 0153-CSP-002
    • W81XWH1920065
    First Posted:
    Jun 1, 2023
    Last Update Posted:
    Jun 1, 2023
    Last Verified:
    May 1, 2023
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    Yes
    Keywords provided by Checkpoint Surgical Inc.
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Jun 1, 2023